Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice

BACKGROUND: Chronic exposure to excess glucocorticoids is frequently associated with a specific cardiomyopathy. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has beneficial effects as it aids in the reduction of heart failure and cardiovascular mortality in hospitalized patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing-Qing, Li, Guo-Qing, Zhong, Yi, Wang, Jie, Wang, An-Ning, Zhou, Xiao, Mao, Xiao-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705186/
https://www.ncbi.nlm.nih.gov/pubmed/33294147
http://dx.doi.org/10.1177/2040622320974833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705186/
https://www.ncbi.nlm.nih.gov/pubmed/33294147
http://dx.doi.org/10.1177/2040622320974833

Ejemplares similares